
Dove Medical Press Ltd is an online open access academic publisher specialising in science, technology and especially medicine. All 80 peer-reviewed journals are free to access online, allowing authors to disseminate their research to a global audience. Most of our journals are widely indexed in databases such as PubMed, Scopus and DOAJ, and an increasing number have Impact Factors. We are a member of OASPA, COPE and HINARI, and are committed to publishing good scientific research and giving authors around the world the opportunity to publish and share their research findings. We have an efficient and rigorous peer-review process. Due to this, many of our journals are able to provide authors with an initial editorial decision within four to five weeks. We aim to provide the highest possible standard of service to our authors. Recent feedback from an author survey demonstrated that: • 100% of authors surveyed found the online manuscript system easy to use • 100% of authors surveyed agreed that they received professional accurate service • 97% of authors surveyed would submit a manuscript with us again • 96% of authors surveyed received prompt communication throughout the publishing process • 86% of authors surveyed rated their level of satisfaction as Excellent (the other 14% rated us as good) To view testimonials from more of our authors please visit: https://www.dovepress.com/testimonials.php We have offices in the United Kingdom, USA and New Zealand. Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC.
最近 90 天内有 1 个信号。
该公司进入各个市场的顺序 — 从最早到最新
和铂医药宣布HBM9378的I期临床试验结果积极
注册以查看完整信号动态
Dove Medical Press 的国际扩张与竞争对手的对比情况
条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
Dove Medical Press你 | 1 | 1 | -100% | 1 | 11 |
当前没有招聘
注册以跟踪该公司,并在发生变化时第一时间获得提醒。
没有进行中的营销活动
注册以跟踪该公司,并在发生变化时第一时间获得提醒。
和铂医药的HBM9378(针对TSLP的新型抗体)I期试验显示良好安全性和延长半衰期,支持进一步开发用于严重免疫疾病。
研究发现结合ESR和CRP测试可减少误诊,为739张床位的医院每年节省995万美元,挑战取消ESR测试的呼声。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Dove Medical Press 的业务、市场和增长信号的快速解答。
